Farmoz

Farmoz is a leading Portuguese pharmaceutical company specializing in the development and commercialization of generic medicines. Founded in 1994 and headquartered in Carnaxide, the company has established a strong reputation for providing high-quality, affordable healthcare solutions across the Iberian market. In 2020, Farmoz was acquired by Neuraxpharm, a prominent European specialty pharmaceutical group focused on Central Nervous System (CNS) disorders. This acquisition integrated Farmoz into a broader European network, enhancing its portfolio in neurology and psychiatry. The company's offerings include a wide range of prescription drugs and consumer health products, with a significant focus on CNS, pain management, and cardiovascular health.